Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Before and After HACE for HCC
NCT00949182Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Jul 2009
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Rutgers University. Started Jul 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00949182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949182.